$POAI
Predictive Oncology Inc.

2016 Form 10-K Financial Statement

#000117184317001534 Filed on March 15, 2017

View on sec.gov

Income Statement

Concept 2016 2015 Q4 2015
Revenue $456.5K $180.0K $654.4K
YoY Change -30.24% 5.88% -31.23%
Cost Of Revenue $181.6K $100.0K $304.0K
YoY Change -40.25% -16.67% -21.11%
Gross Profit $274.9K $80.00K $350.4K
YoY Change -21.55% 100.0% -38.12%
Gross Profit Margin 60.21% 44.44% 53.54%
Selling, General & Admin $5.643M $1.870M $3.903M
YoY Change 44.56% -4.59% -35.6%
% of Gross Profit 2052.85% 2337.5% 1114.05%
Research & Development $406.0K $261.0K
YoY Change 55.56% -33.76%
% of Gross Profit 147.7% 74.49%
Depreciation & Amortization $82.36K $20.00K $78.57K
YoY Change 4.82% 0.0% 24.63%
% of Gross Profit 29.96% 25.0% 22.42%
Operating Expenses $6.049M $2.350M $4.164M
YoY Change 45.25% 6.82% -35.49%
Operating Profit -$5.774M -$2.270M -$3.814M
YoY Change 51.39% 5.09% -35.23%
Interest Expense $3.00 $0.00 $390.9K
YoY Change -100.0% -100.0% 3.49%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$6.530M -$2.260M -$4.790M
YoY Change 36.33% -4.64% -29.87%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$6.530M -$2.260M -$4.790M
YoY Change 36.33% -4.64% -29.9%
Net Earnings / Revenue -1430.46% -1255.56% -732.02%
Basic Earnings Per Share
Diluted Earnings Per Share -$23.32M -$113.0M -$239.5M
COMMON SHARES
Basic Shares Outstanding 2.823M 155.2K
Diluted Shares Outstanding

Balance Sheet

Concept 2016 2015 Q4 2015
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.150M $4.860M $4.860M
YoY Change -55.76% 24200.0% 24200.0%
Cash & Equivalents $4.856M
Short-Term Investments $380.0K
Other Short-Term Assets $150.0K $270.0K $270.0K
YoY Change -44.44% 42.11% 42.11%
Inventory $270.0K $231.7K $230.0K
Prepaid Expenses
Receivables $40.00K $38.28K $40.00K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $2.610M $5.398M $5.400M
YoY Change -51.67% 755.01% 757.14%
LONG-TERM ASSETS
Property, Plant & Equipment $100.0K $139.6K $140.0K
YoY Change -28.57% -28.95% -30.0%
Goodwill
YoY Change
Intangibles $94.99K
YoY Change 29.79%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $200.0K $234.6K $230.0K
YoY Change -13.04% -13.01% -14.81%
TOTAL ASSETS
Total Short-Term Assets $2.610M $5.398M $5.400M
Total Long-Term Assets $200.0K $234.6K $230.0K
Total Assets $2.810M $5.632M $5.630M
YoY Change -50.09% 525.15% 525.56%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $220.0K $650.4K $650.0K
YoY Change -66.15% -70.36% -70.32%
Accrued Expenses $1.350M $864.3K $860.0K
YoY Change 56.98% -71.81% -71.99%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.570M $1.520M $1.520M
YoY Change 3.29% -75.5% -75.48%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $310.0K $0.00 $0.00
YoY Change -100.0% -100.0%
Total Long-Term Liabilities $310.0K $0.00 $0.00
YoY Change -100.0% -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.570M $1.520M $1.520M
Total Long-Term Liabilities $310.0K $0.00 $0.00
Total Liabilities $1.880M $1.520M $1.520M
YoY Change 23.68% -76.32% -76.32%
SHAREHOLDERS EQUITY
Retained Earnings -$40.49M
YoY Change
Common Stock $2.080K
YoY Change -99.99%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $920.0K $4.113M $4.110M
YoY Change
Total Liabilities & Shareholders Equity $2.810M $5.632M $5.630M
YoY Change -50.09% 525.15% 525.56%

Cashflow Statement

Concept 2016 2015 Q4 2015
OPERATING ACTIVITIES
Net Income -$6.530M -$2.260M -$4.790M
YoY Change 36.33% -4.64% -29.9%
Depreciation, Depletion And Amortization $82.36K $20.00K $78.57K
YoY Change 4.82% 0.0% 24.63%
Cash From Operating Activities -$4.381M -$2.850M -$7.490M
YoY Change -41.5% 1139.13% 122.26%
INVESTING ACTIVITIES
Capital Expenditures $32.76K -$40.00K $32.47K
YoY Change 0.89% -67.98%
Acquisitions
YoY Change
Other Investing Activities -$380.0K
YoY Change
Cash From Investing Activities -$422.9K -$40.00K -$60.00K
YoY Change 604.77% -50.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $1.712M $13.05M
YoY Change -86.88% 8208.98%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.712M 10.00K 12.39M
YoY Change -86.18% 263.34%
NET CHANGE
Cash From Operating Activities -4.381M -2.850M -7.490M
Cash From Investing Activities -422.9K -40.00K -60.00K
Cash From Financing Activities 1.712M 10.00K 12.39M
Net Change In Cash -3.092M -2.880M 4.840M
YoY Change -163.89% 1152.17% -6150.0%
FREE CASH FLOW
Cash From Operating Activities -$4.381M -$2.850M -$7.490M
Capital Expenditures $32.76K -$40.00K $32.47K
Free Cash Flow -$4.414M -$2.810M -$7.522M
YoY Change -41.32% 1121.74% 116.7%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2016 dei Amendment Flag
AmendmentFlag
false
CY2016 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2016
CY2016 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2016 dei Document Period End Date
DocumentPeriodEndDate
2016-12-31
CY2016 dei Document Type
DocumentType
10-K
CY2016Q2 dei Entity Public Float
EntityPublicFloat
11767746
CY2015 skln Proceeds From Redemption Of Certificates Of Deposits
ProceedsFromRedemptionOfCertificatesOfDeposits
CY2016Q4 skln Class Of Warrant Or Right Number Of Warrants Vested And Exercisable
ClassOfWarrantOrRightNumberOfWarrantsVestedAndExercisable
114102
CY2015Q4 skln Class Of Warrant Or Right Number Of Warrants Vested And Exercisable
ClassOfWarrantOrRightNumberOfWarrantsVestedAndExercisable
114102
CY2016 skln Class Of Warrant Or Right Outstanding Weighted Average Remaining Contractual Term
ClassOfWarrantOrRightOutstandingWeightedAverageRemainingContractualTerm
CY2016 skln Common Stock Issued To Satisfy Debt
CommonStockIssuedToSatisfyDebt
CY2015 skln Common Stock Issued To Satisfy Debt
CommonStockIssuedToSatisfyDebt
483478
CY2016 skln Corrections Due To Rounding For Reverse Stock Split Value
CorrectionsDueToRoundingForReverseStockSplitValue
-1
CY2016 skln Equity Instruments Issued For Management And Consulting
EquityInstrumentsIssuedForManagementAndConsulting
721330
CY2015 skln Equity Instruments Issued For Management And Consulting
EquityInstrumentsIssuedForManagementAndConsulting
-6667
CY2016 skln Lessee Leasing Arrangements Operating Leases Extension Term
LesseeLeasingArrangementsOperatingLeasesExtensionTerm
P5Y
CY2016 skln Lessee Leasing Arrangements Operating Leases Terms Of Contract Cancellation
LesseeLeasingArrangementsOperatingLeasesTermsOfContractCancellation
P3Y
CY2016 skln Operating And Nonoperating Expense Total
OperatingAndNonoperatingExpenseTotal
6800889
CY2015 skln Operating And Nonoperating Expense Total
OperatingAndNonoperatingExpenseTotal
5140902
CY2015Q3 skln Option Granted To Underwriter To Purchase Additional Units Number Of Units Granted
OptionGrantedToUnderwriterToPurchaseAdditionalUnitsNumberOfUnitsGranted
250000
CY2015Q3 skln Option Granted To Underwriter To Purchase Additional Units Period
OptionGrantedToUnderwriterToPurchaseAdditionalUnitsPeriod
P45D
CY2016 skln Penalty On Debt Provision
PenaltyOnDebtProvision
CY2015 skln Penalty On Debt Provision
PenaltyOnDebtProvision
10031
CY2016 skln Proceeds From Long Term And Convertible Debt
ProceedsFromLongTermAndConvertibleDebt
CY2015 skln Proceeds From Long Term And Convertible Debt
ProceedsFromLongTermAndConvertibleDebt
250000
CY2016 skln Proceeds From Redemption Of Certificates Of Deposits
ProceedsFromRedemptionOfCertificatesOfDeposits
1000000
CY2015 skln Reduction In Escrow Account Per Settlement Agreement Value
ReductionInEscrowAccountPerSettlementAgreementValue
6667
CY2016 skln Repayments Of Debt Principal
RepaymentsOfDebtPrincipal
CY2015 skln Repayments Of Debt Principal
RepaymentsOfDebtPrincipal
933074
CY2015 skln Stock Issued During Period Value Preferred Stock Conversion
StockIssuedDuringPeriodValuePreferredStockConversion
CY2015 skln Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
9900
CY2016 skln Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
579666
CY2015Q3 skln Underwriter Price
UnderwriterPrice
8.28
CY2015Q3 skln Underwriting Agreement Nonaccountable Expense Allowance Percentage
UnderwritingAgreementNonaccountableExpenseAllowancePercentage
0.01
CY2015Q3 skln Underwriting Commission
UnderwritingCommission
0.08
CY2015Q3 skln Underwriting Discount
UnderwritingDiscount
0.72
CY2016 skln Valuation Allowance Percentage
ValuationAllowancePercentage
1
CY2016Q4 us-gaap Accounts Payable And Accrued Liabilities Noncurrent
AccountsPayableAndAccruedLiabilitiesNoncurrent
309649
CY2015Q4 us-gaap Accounts Payable And Accrued Liabilities Noncurrent
AccountsPayableAndAccruedLiabilitiesNoncurrent
CY2016Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
220112
CY2015Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
650413
CY2016Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
38919
CY2015Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
38283
CY2016Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1346105
CY2015Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
864295
CY2016Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
214897
CY2015Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
144079
CY2016Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1501
CY2015Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
CY2016Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
47894196
CY2015Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
44584118
CY2016 us-gaap Adjustment Of Warrants Granted For Services
AdjustmentOfWarrantsGrantedForServices
736725
CY2015 us-gaap Adjustment Of Warrants Granted For Services
AdjustmentOfWarrantsGrantedForServices
CY2015 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
871877
CY2016 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
165271
CY2016 us-gaap Advertising Expense
AdvertisingExpense
71212
CY2015 us-gaap Advertising Expense
AdvertisingExpense
8220
CY2016 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
165271
CY2015 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
871877
CY2016 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
CY2015 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
219097
CY2016 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
9107
CY2015 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
6291
CY2016Q4 us-gaap Assets
Assets
2807546
CY2015Q4 us-gaap Assets
Assets
5632419
CY2016Q4 us-gaap Assets Current
AssetsCurrent
2608183
CY2015Q4 us-gaap Assets Current
AssetsCurrent
5397834
CY2016Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
284329
CY2015Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
CY2016 us-gaap Available For Sale Securities Gross Realized Gain Loss Net
AvailableForSaleSecuritiesGrossRealizedGainLossNet
4716
CY2015 us-gaap Available For Sale Securities Gross Realized Gain Loss Net
AvailableForSaleSecuritiesGrossRealizedGainLossNet
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1764090
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4856232
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
16384
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4564428
CY2015Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
208258
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
45644
CY2015Q4 us-gaap Common Stock Value
CommonStockValue
2080
CY2016 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-6524513
CY2015 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4790530
CY2016 us-gaap Cash Period Increase Decrease
CashPeriodIncreaseDecrease
-3092142
CY2015 us-gaap Cash Period Increase Decrease
CashPeriodIncreaseDecrease
4839848
CY2016Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
1652438
CY2016Q4 us-gaap Certificates Of Deposit At Carrying Value
CertificatesOfDepositAtCarryingValue
100000
CY2015Q4 us-gaap Certificates Of Deposit At Carrying Value
CertificatesOfDepositAtCarryingValue
CY2016Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
871101
CY2016Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2015Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2015Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
24000000
CY2015Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
24000000
CY2016Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2016Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
8000000
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4564428
CY2016 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><div style="display: inline; font-weight: bold;">Credit Risk </div></div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Financial instruments which potentially subject the Company to concentrations of credit risk consist principally of cash. The Company places its cash with high credit quality financial institutions and, by policy, generally limits the amount of credit exposure to any <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> financial institution. The Company had a credit risk concentration as a result of depositing <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1,652,438</div> of funds in excess of insurance limits in a single bank.</div></div></div>
CY2016 us-gaap Cost Of Goods Sold
CostOfGoodsSold
181620
CY2015 us-gaap Cost Of Goods Sold
CostOfGoodsSold
303982
us-gaap Debt Instrument Increase Decrease For Period Net
DebtInstrumentIncreaseDecreaseForPeriodNet
5685000
CY2016Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
7998
CY2015Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
5000
CY2016Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
10944000
CY2015Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
10697000
CY2016Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2015Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2016Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
10755000
CY2015Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
10338000
CY2016Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
189000
CY2015Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
359000
CY2016Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
10944000
CY2015Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
10697000
CY2016 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
33143
CY2015 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
39916
CY2016 us-gaap Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
1
CY2015 us-gaap Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
1
CY2016 us-gaap Defined Contribution Plan Maximum Annual Contributions Per Employee Percent
DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent
0.04
CY2015 us-gaap Defined Contribution Plan Maximum Annual Contributions Per Employee Percent
DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent
0.04
CY2016 us-gaap Depreciation
Depreciation
73249
CY2015 us-gaap Depreciation
Depreciation
72275
CY2016 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
82356
CY2015 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
78566
CY2016 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.31
CY2015 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-30.86
CY2016Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
223205
CY2016 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
2387
CY2015 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-17076
CY2016 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5174799
CY2015 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3399339
CY2015 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-2415967
CY2016 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
2998
CY2015 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
CY2016 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
40468
CY2015 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-135627
CY2016 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-122943
CY2015 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
81564
CY2016 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
CY2015 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
CY2016 us-gaap Gross Profit
GrossProfit
274875
CY2015 us-gaap Gross Profit
GrossProfit
350372
CY2016 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2016 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-430301
CY2015 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1544105
CY2016 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
636
CY2015 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-19266
CY2016 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
791459
CY2016Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
97867
CY2015Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
94987
CY2016 us-gaap Interest Expense
InterestExpense
3
CY2015 us-gaap Interest Expense
InterestExpense
390887
CY2016 us-gaap Interest Paid
InterestPaid
3
CY2016 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
11987
CY2015 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
28095
CY2016Q4 us-gaap Inventory Net
InventoryNet
272208
CY2015Q4 us-gaap Inventory Net
InventoryNet
231740
CY2015 us-gaap Interest Paid
InterestPaid
246620
CY2016Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
38201
CY2015Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
30237
CY2016Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
165812
CY2015Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
162623
CY2016Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
68195
CY2015Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
38880
CY2016 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
66239
CY2015 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
66345
CY2016Q4 us-gaap Liabilities
Liabilities
1883864
CY2015Q4 us-gaap Liabilities
Liabilities
1519708
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2807546
CY2015Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5632419
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1574215
CY2015Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1519708
CY2016 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
1712158
CY2015 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
12387706
CY2016 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-422860
CY2015 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-60565
CY2016 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-4381440
CY2015 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-7487293
CY2016 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-6526014
CY2015 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-4790530
CY2016 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2016 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
1158117
CY2015 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
846687
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
39000
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
3000
CY2015 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
CY2016 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
1501
CY2016 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
850000
CY2015 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
CY2016 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
32760
CY2015 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
32470
CY2016 us-gaap Payments To Acquire Restricted Certificates Of Deposit
PaymentsToAcquireRestrictedCertificatesOfDeposit
1100000
CY2015 us-gaap Payments To Acquire Restricted Certificates Of Deposit
PaymentsToAcquireRestrictedCertificatesOfDeposit
CY2016Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
148637
CY2015Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
271579
CY2016 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1712158
CY2015 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
13051830
CY2016 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
CY2015 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
18950
CY2015Q3 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
13800000
CY2016 us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
571887
CY2015 us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
CY2016 us-gaap Product Warranty Expense
ProductWarrantyExpense
34665
CY2015 us-gaap Product Warranty Expense
ProductWarrantyExpense
56201
CY2016Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
316393
CY2015Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
283677
CY2016Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
101496
CY2015Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
139598
CY2016 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
406000
CY2015 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
261000
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-47018451
CY2015Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-40492437
CY2016 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
456495
CY2015 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
654354
CY2016 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
467970
CY2015 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
503989
CY2016 us-gaap Share Based Compensation
ShareBasedCompensation
165271
CY2015 us-gaap Share Based Compensation
ShareBasedCompensation
871877
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.66
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.66
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.59
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.59
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
165643
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
71209
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
21.62
CY2016 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
65.75
CY2016Q3 us-gaap Share Price
SharePrice
4.125
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P9Y120D
CY2015Q3 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
9
CY2016Q4 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
400000
CY2015 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
13060880
CY2016 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
86253
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
923682
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
4112711
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
-5516227
CY2016 us-gaap Stockholders Equity Period Increase Decrease
StockholdersEquityPeriodIncreaseDecrease
23950996
CY2016 us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><div style="display: inline; font-weight: bold;">Accounting Policies and Estimates</div></div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The presentation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</div></div></div>
CY2016 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
2823345
CY2015 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
155233
CY2016 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2823345
CY2015 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
155233

Files In Submission

Name View Source Status
0001171843-17-001534-index-headers.html Edgar Link pending
0001171843-17-001534-index.html Edgar Link pending
0001171843-17-001534.txt Edgar Link pending
0001171843-17-001534-xbrl.zip Edgar Link pending
exh_231.htm Edgar Link pending
exh_311.htm Edgar Link pending
exh_312.htm Edgar Link pending
exh_321.htm Edgar Link pending
f10k_031517p.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
skln-20161231.xml Edgar Link completed
skln-20161231.xsd Edgar Link pending
skln-20161231_cal.xml Edgar Link unprocessable
skln-20161231_def.xml Edgar Link unprocessable
skln-20161231_lab.xml Edgar Link unprocessable
skln-20161231_pre.xml Edgar Link unprocessable